Cbd and Cyclosporine: Can You Take Them Together?

High: Consult Your DoctorConflict
Learn about each ingredient:CbdCyclosporine

Quick answer

CBD (cannabidiol) can raise blood levels of oral drugs handled by the P-glycoprotein (P-gp) transporter, and cyclosporine is a P-gp substrate. The Epidiolex (prescription CBD) label says exposure to orally taken P-gp substrates such as sirolimus and tacrolimus may increase and advises drug-level monitoring and dose reduction; it does not name cyclosporine, but CBD raised exposure to everolimus, another transplant drug handled by P-gp, about 2.5-fold in healthy adults, while it did not change levels of midazolam, a CYP3A4 test drug. A case report described a pharmacokinetic interaction between CBD and cyclosporine in a kidney transplant recipient, but its abstract gives no numbers, so the size of the effect is not known.

Treat starting, stopping or changing a CBD product like a medication change: ask your transplant team or prescriber first, since your cyclosporine level may need extra checks. Tell them about any CBD you already use, including oils, gummies and capsules.

What happens?

Cyclosporine is dosed by blood level. CBD can raise levels of oral drugs handled by the P-glycoprotein transporter, which also handles cyclosporine.

1

Shared pathways

Cyclosporine is pumped by P-glycoprotein, the transporter the Epidiolex label points to for CBD's effect on other transplant drugs.

2

Label warning

The Epidiolex label says CBD may raise exposure to oral P-gp substrates such as tacrolimus and sirolimus and advises level monitoring.

3

Related drug data

CBD raised exposure to everolimus, another P-gp and CYP3A4 substrate, about 2.5-fold in healthy adults.

In healthy adults, prescription CBD raised exposure to everolimus, a transplant drug handled by P-glycoprotein like cyclosporine, about <strong>2.5-fold</strong>.

Why is this important?

An unplanned rise in cyclosporine can increase the risk of kidney damage, and the size of the CBD effect is not known.

Toxicity

Higher cyclosporine levels raise the risk of kidney damage and other toxicity described in its labels.

Unknown size

There is no controlled study with cyclosporine, and consumer CBD strengths vary widely.

Stopping matters

Stopping CBD after a dose adjustment could let cyclosporine levels fall.

Stopping CBD after a dose adjustment can have the opposite effect.

What should you do?

The practical fix is simple: separate the doses.

Treat any CBD change like a medication change

Best practical schedule

Before starting
Check labels for CBD, cannabidiol, hemp extract or full-spectrum hemp, and ask your transplant team or prescriber first.
Every day
Take cyclosporine as prescribed, keep your blood-level tests and stay on a CBD product only if your team knows about it.
After a change
If you have been using CBD, tell your team rather than stopping on your own.

Important reminders

  • •The size of the effect of consumer CBD on cyclosporine is unknown.
  • •Products may list CBD as hemp extract or full-spectrum hemp.

For tacrolimus, a related transplant drug, high-dose CBD raised exposure about threefold in healthy adults; cyclosporine has not been studied the same way.

Which specific products are affected?

Many common Cyclosporine products can affect this interaction.

Cyclosporine products this applies to

Neoral (cyclosporine, modified) capsules and oral solutionSandimmune (cyclosporine) capsulesGengraf (cyclosporine, modified)Generic cyclosporine capsules and oral solution

Where CBD shows up

Epidiolex (prescription cannabidiol)CBD oils and tincturesCBD gummies and capsulesCBD drinksHemp extract and full-spectrum hemp products

Other sources

  • •Cyclosporine eye drops (such as Restasis) are applied to the eye rather than swallowed and were not part of these sources; mention them to your clinician anyway.
  • •Topical CBD products were not part of these sources; mention them to your team.

CBD strength varies widely between consumer products, so tell your team the exact product you use.

The bottom line

CBD can raise blood levels of oral drugs handled by the P-glycoprotein transporter, and cyclosporine is one of them. The Epidiolex label advises level monitoring and dose reduction for related transplant drugs, and a case report described a CBD and cyclosporine interaction in a kidney transplant recipient, though its size is unknown. Ask your team before starting, stopping or changing any CBD product.

If you already use CBD, tell your team rather than stopping on your own, since your level may change.

What happens when you take CBD with cyclosporine?

Cyclosporine (Neoral, Sandimmune, Gengraf) is an immunosuppressant used to prevent rejection after kidney, liver and heart transplants, and Neoral is also used for severe rheumatoid arthritis and psoriasis. It is dosed by blood level because the safe range is narrow. CBD (cannabidiol) is sold as oils, gummies and capsules for pain, sleep and anxiety. CBD can raise blood levels of drugs that cyclosporine resembles in how the body handles them.

  1. Cyclosporine is broken down mainly by CYP3A4 and is pumped by the P-glycoprotein (P-gp) transporter, according to its label.
  2. The Epidiolex label warns that CBD may increase exposure to drugs taken by mouth that depend on P-gp, naming sirolimus, tacrolimus and digoxin.
  3. In healthy adults, prescription CBD raised exposure to everolimus, a transplant drug handled by both P-gp and CYP3A4, about 2.5-fold.
  4. In the same label, CBD did not change levels of midazolam, a drug used to test CYP3A4, so the label points to the P-gp route. Cyclosporine is also a P-gp substrate, so its levels may rise too. A case report in a kidney transplant recipient described such an interaction, but its size has not been measured.

Why is this important?

A rise in cyclosporine levels can increase the risk of kidney damage and other toxicity, which the cyclosporine labels describe. Stopping CBD after a dose has been adjusted could have the opposite effect and let levels fall.

Consumer CBD products vary in strength, and the studies behind the Epidiolex warning used prescription doses. How much a typical consumer product affects cyclosporine is not known, which is a reason to involve your team rather than a reason for reassurance.

For tacrolimus, a related transplant drug, a study in 12 healthy adults (So GC, et al. Clin Pharmacol Ther. 2025) found that high-dose CBD raised exposure about threefold. Cyclosporine has not been studied the same way.

What should you do?

The principle: treat any start, stop or change in a CBD product as a medication change, and tell your team first.

Before starting: Check product labels for CBD, cannabidiol, hemp extract or full-spectrum hemp. Ask your transplant team or prescriber before using any of them.

Every day while on cyclosporine: Take cyclosporine exactly as prescribed and keep your blood-level tests. Keep using the same CBD product only if your team knows about it.

After a change: If you have been using CBD, tell your team rather than stopping on your own, so they can decide whether to check your level.

Which specific products are affected?

On the medication side, this applies to oral cyclosporine: Neoral, Sandimmune, Gengraf and generic cyclosporine capsules and oral solution. Cyclosporine eye drops (such as Restasis) are applied to the eye rather than swallowed and were not part of these sources; mention them to your clinician anyway.

On the CBD side, it covers prescription Epidiolex and consumer CBD oils, tinctures, gummies, capsules and drinks, including products labeled hemp extract or full-spectrum hemp. Topical CBD was not part of these sources.

The science behind it

The Epidiolex label (section 7.2) says increases in exposure of orally administered P-gp substrates such as sirolimus, tacrolimus and digoxin may be observed with CBD, and advises therapeutic drug monitoring and dose reduction. Its section 12.3 reports that CBD raised everolimus peak level and AUC about 2.5-fold in healthy subjects, and did not change levels of the CYP3A4 test drug midazolam. The Neoral label states that cyclosporine is extensively metabolized by CYP3A4 and is a P-glycoprotein substrate.

A case report (Cuñetti L, et al. Transplant Proc. 2024) described a pharmacokinetic interaction between CBD, cyclosporine and mycophenolate in a kidney transplant recipient and advised monitoring drug levels; the abstract does not report the size of the change. A 2014 review (Colombo D, et al. J Toxicol.) notes that CBD increased cyclosporine levels in animal studies.

What has not been shown: there is no controlled study of CBD with cyclosporine in people, and no data on typical consumer CBD amounts. One case report is a signal, not proof.

Frequently Asked Questions

Can I use CBD oil while on cyclosporine?

Ask your transplant team or prescriber first. CBD may raise cyclosporine levels, and your team may want to check your level.

Is a low-dose CBD gummy a problem?

Nobody knows how much a small consumer dose affects cyclosporine. The label warning is based on prescription doses, so involve your team either way.

Does hemp extract count as CBD?

Often, yes. Many products list CBD as hemp extract or full-spectrum hemp, so check the label.

What if I have been using CBD for a while?

Tell your team rather than stopping on your own. Your current level may already reflect the CBD, and stopping could change it.

Is CBD cream a concern?

Topical CBD was not part of these sources. Mention it to your team so they have the full picture.

Key takeaways

  • CBD can raise levels of oral drugs handled by the P-gp transporter, and cyclosporine is one of them.
  • The Epidiolex label advises drug-level monitoring and dose reduction for P-gp substrates such as tacrolimus and sirolimus.
  • One case report described a CBD and cyclosporine interaction in a kidney transplant recipient; its size is unknown.
  • Labels may say hemp extract or full-spectrum hemp instead of CBD.
  • Treat any start, stop or change in CBD as a medication change and tell your team first.

References

Primary evidence for this article. Always consult your healthcare provider for personal medical advice.

Related Interactions

Other interactions you should know about

Grapefruit + Sirolimus

high

Sirolimus is a CYP3A4 and P-glycoprotein substrate with a narrow therapeutic window and high patient-to-patient variability. The FDA-approved Rapamune label states that grapefruit juice inhibits the CYP3A4-mediated metabolism of sirolimus and must not be taken with, or used to dilute, the drug, because unpredictable rises in blood levels can cause toxicity and threaten the transplanted organ.

Tacrolimus + St. John's Wort

critical

St. John's wort induces the CYP3A4 enzyme and the P-glycoprotein transporter, which speeds up clearance of tacrolimus and lowers its blood levels, raising the risk of transplant rejection. Stopping the herb lets tacrolimus levels climb back up, which can push them too high if the dose was raised in the meantime; high tacrolimus levels can harm the kidneys.

Digoxin + St. John's Wort

high

St. John's wort revs up a gut transporter that digoxin depends on for absorption, so combining them quietly drains digoxin from the bloodstream. Because digoxin has so little room to spare, that drop can leave the drug too weak to control your heart.

Cbd + Simvastatin

low

Simvastatin is cleared mainly by the liver enzyme CYP3A4, and CBD inhibits that same enzyme in laboratory studies. Combining them could raise simvastatin exposure, which could increase the risk of muscle pain and, rarely, more serious muscle injury. This is a predicted interaction, not a confirmed one: the Epidiolex label reports that CBD did not change levels of midazolam, a sensitive CYP3A4 drug, and we found no human study of CBD with simvastatin.

Rivaroxaban + St. John's Wort

high

St. John's wort speeds up CYP3A4 and P-glycoprotein, the enzyme and the transporter that clear rivaroxaban, so rivaroxaban levels fall and its protection against clots may weaken. The Xarelto label says to avoid rivaroxaban with drugs that are combined P-gp and strong CYP3A inducers and names St. John's wort among them. In two small studies, each in 12 healthy volunteers, St. John's wort lowered rivaroxaban exposure by 24 and 25 percent, and in one of them its anti-clotting effect (factor Xa inhibition) fell by 20 percent; no study has measured clots or strokes from the pair.

Verapamil + St. John's Wort

high

St. John's wort is a potent inducer of intestinal CYP3A4 and P-glycoprotein, the same enzymes that break down verapamil before it reaches the bloodstream. Taking the two together sharply lowers verapamil's systemic exposure and can erase its therapeutic effect on blood pressure, heart rhythm, or migraine prevention.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making changes to your supplement or medication routine. Pilora does not diagnose, treat, cure, or prevent any disease.

Check all your supplement interactions instantly

Try Pilora Free